Global Cephalosporin Drugs Market to Register a CAGR of 5.2% during the forecast period

The Global Cephalosporin Drugs Market was valued at USD 11.6 Billion in 2018 and it is expected to register a CAGR of 5.2% over the forecast period. Cephalosporin drugs are bactericidal beta lactam antibiotics. They hinder bacterial growth by inhibiting the synthesis of the bacterial cell wall, and are effective in preventing the growth of all bacterial forms, i.e., both gram-positive and gram-negative bacteria.

Cephalosporin was first prepared in 1948 by Dr. Abraham. Cephalosporin pharmaceutical products are called broad-spectrum antibiotics. They have similar actions to ampicillin and are considered an alternative to penicillin for many patients. This has supported the growth of the global market over the years.

Cephalosporin products are used to treat infections of various parts of the body, including lungs, head, sinuses, nose, mouth, and skin. Further, there has been increasing usage of cephalosporin in dermatological applications, which is likely to further boost the growth of the global cephalosporin drugs market.

These drugs are also used for the treatment of influenza, staph infections, bronchitis, strep throat, tonsillitis, and gonorrhoea. Based on antimicrobial efficacy, cephalosporin drugs can be divided into five groups or generations. For each newer generation of cephalosporin, the gram-negative antimicrobial potential has dramatically improved, which has proved immensely helpful.

All the above applications of cephalosporin to combat harmful diseases or infections are anticipated to fuel the expansion of the global cephalosporin drugs market in the near future. However, these medications are contraindicated for people who are allergic to these drugs or who have an anaphylactic reaction to penicillin.

The global cephalosporin drugs market is expected to expand dramatically due to the growing demand for anti-microbial medicinal products in different indications. Other factors in driving the growth of the market include increasing research & development activities, increasing awareness among patients, and the rising occurrence of infectious diseases.

Awareness programs like European Antibiotics Awareness Day, which is celebrated on November 18 every year, is playing a crucial role in raising the level of awareness about antibiotic resistance and the judicious use of antibiotics. Such programs are also playing an important role in propelling the growth of the cephalosporin market.

However, strict government regulations and generic saturation of these drugs may hamper the growth of the market to some extent. Further, poor pipeline molecules and the emergence of drug resistance in patients are some of the major challenges for the global cephalosporin market. Apart from these, factors such as growing mergers and acquisitions, the use of combination treatments for patients, and the production of highly effective cephalosporin products are going to give a major impetus to the growth of the global market.

Global Cephalosporin Drugs Market, By Generation

Based on generation, the cephalosporin drugs market has been segmented into first-generation cephalosporin, second-generation cephalosporin, third-generation cephalosporin, fourth-generation cephalosporin, and fifth- generation cephalosporin. Due to its activity against gram-positive bacteria such as streptococci and staphylococci, the first generation cephalosporin products have witnessed higher sales than others. These also have antimicrobial activity with a gram-negative spectrum. This factor is promoting the growth of the first-generation cephalosporin segment.

Global Cephalosporin Drugs Market, By Route of Administration

The global market for cephalosporin has been segmented into injection and oral, depending on the route of administration. Injection is the most preferred route of drug administration due to quick drug delivery, which has led to the growth of this segment.

Global Cephalosporin Drugs Market, By Type

The global market segmentation, by type, includes generic and branded. The cost of medicine is a major concern today. Generic drugs provide major cost-saving benefits and help reduce healthcare expenditure since they are available at lower prices. However, many physicians and patients are apprehensive about their quality, although they are bio-equivalents of branded drugs. But still, due to their affordability, the generic segment, particularly in regions with mid and lower income population, is expected to grow over the forecast period.

Global Cephalosporin Drugs Market, By Application

Based on application, the global market for cephalosporin has been segmented into respiratory tract infection, skin infection, ear infection, sexually transmitted infection, and others. The respiratory tract infection segment was projected to lead the market in terms of volume in 2018. The growth of the segment can be mainly attributed to the increasing prevalence of respiratory diseases due to numerous factors, such as pollution, unhealthy lifestyle, etc.

Global Cephalosporin Drugs Market, By Regions

Region-wise, the global market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and rest of the world. Increased understanding of cephalosporin drugs among patients, rising demand for a highly integrated health system, and increasing incidence of infectious conditions have driven the market for cephalosporin drugs in the Asia Pacific region. Moreover, owing to the increased prevalence of infectious diseases, the North America region is expected to witness the fastest growth, making it the most lucrative market.

Key Developments in the Global Cephalosporin Drugs Market

  • Merck & Co. announced in June 2019 that the U.S. Food and Drug Administration (FDA) approved its supplementary New Drug Proposal (sNDA) for the use of ZERBAXA (ceftolozane and tazobactam) for the care of patients above 18 years of age with ventilator-associated bacterial pneumonia and hospital-acquired bacterial pneumonia.
  • Lupin Limited in April 2019 received FDA approval in the cephalosporin segment for Ceftriaxone injection and Cefotaxime injection. The filings mark the company's entrance into the U.S. generics markets in this category and the first step in securing a market share for niche cephalosporin molecules.

Some Key Findings of the Global Cephalosporin Drugs Market Report Include:

  • The analysis includes a global cephalosporin drugs market study, expansions, and forecasts, along with a country-specific analysis.
  • An in-depth analysis of the global cephalosporin drugs market comprises segment by generation, by application, by route of administration, by type, and by regions with an analysis of trend-based insights and factors.
  • Product offering details on competitive benchmarking, evolution approach adopted by the industry players, along with their investments in the last five years in the global market have also been included.
  • The market research includes a study of the provinces and boundaries, along with the drivers, prospects, guidelines, challenges, and procedures that are propelling the global market.
  • The study also offers complex norms of potential market effect during the forecast period and provides an in-depth overview of the leading companies operating in the global market for cephalosporin drugs.
  • External as well as internal variables that are expected to have a positive or negative effect on the companies have been evaluated, which will offer the decision-makers a strong futuristic view of the industry.
  • The research will also help understand the dynamics of the cephalosporin drugs market and structure by analyzing market segments and projecting the size of the market.
  • Some major industry players functional in the global cephalosporin drugs market include Ranbaxy, Merck, Sandoz, Pfizer, Astellas, Roche, Bristol-Myers Squibb, Abbott, Lupin Pharmaceuticals, Teva Pharmaceuticals, and Glaxo SmithKline.

Market Segmentation

By Generation

  • First-Generation Cephalosporin
  • Second-Generation Cephalosporin
  • Third-Generation Cephalosporin
  • Fourth-Generation Cephalosporin
  • Fifth-Generation Cephalosporin

By Application

  • Respiratory Tract Infection
  • Skin Infection
  • Ear Infection
  • Sexually-Transmitted Infection
  • Other

By Route of Administration

  • Oral Drugs
  • Injection

By Type

  • Branded
  • Generic

By Region:

  • North America
  • Western Europe
  • Eastern Europe
  • Asia Pacific
  • Middle East
  • Rest of the world
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements